galactosamine has been researched along with Multiple Organ Failure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bhadauria, M; Nirala, SK; Rakshit, S | 1 |
Bohlinger, I; Gantner, F; Germann, PG; Leist, M; Tiegs, G; Wendel, A | 1 |
Fukui, H; Kikuchi, E; Matsumoto, M; Matsumura, M; Tsujii, T; Tsujita, S; Uemura, M | 1 |
3 other study(ies) available for galactosamine and Multiple Organ Failure
Article | Year |
---|---|
Gallic Acid Protects from Acute Multiorgan Injury Induced by Lipopolysaccharide and D-galactosamine.
Topics: Acute Disease; Animals; Antioxidants; Brain; Dose-Response Relationship, Drug; Galactosamine; Gallic Acid; Glutathione; Humans; Kidney; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Multiple Organ Failure; Oxidative Stress; Protective Agents; Rats, Wistar; Superoxide Dismutase | 2020 |
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.
Topics: Animals; Apoptosis; Dactinomycin; DNA; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiple Organ Failure; Proteins; RNA; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |
Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failure.
Topics: Alprostadil; Animals; Galactosamine; Hepatic Encephalopathy; Male; Multiple Organ Failure; Rabbits; Regional Blood Flow | 1994 |